3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer

Radiotherapy and Oncology

Volumn 71, Issue 1, 2004, Pages 35-41

  Martin, Thomas ^a   Röddiger, Sandra ^a   Kurek, Ralf ^a   Dannenberg, Thomas ^b   Eckart, Oliver ^b   Kolotas, Christos ^a   Heyd, Reinhard ^a   Rogge, Bernd ^a   Baltas, Dimos ^a   Tunn, Ulf ^b   Zamboglou, Nikolaos ^a  

^a Klinikum Offenbach GmbH   (Germany)

^b Klinikum Offenbach   (Germany)

Author keywords

3D external beam radiation; Androgen deprivation; HDR brachytherapy; Prostate cancer

Indexed keywords

ANDROGEN; ANTIANDROGEN; GONADORELIN ANTAGONIST;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; EVALUATION; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HISTOGRAM; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITATIVE ANALYSIS; RADIATION DOSE; RADIOTHERAPY; RECTUM FISTULA; SURVIVAL RATE; SURVIVAL TIME; TOXICITY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; BRACHYTHERAPY; COMBINED MODALITY THERAPY; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 11144354809     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.10.004     Document Type: Article

References (36)

1. ASTRO Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
2. Bolla M., Gonzales D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 337:1997;304-309.
3. Borghede G., Hedelin H., Holmang S., Johansson K.A., Sernbo G., Mercke C. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. Radiother Oncol. 44:1997;245-250.
4. Brabbins D.S., Yan D., Lockman D., et al. Treatment of prostate cancer using a proactive decision-making process. Radiother Oncol. 48:(Suppl. 1):1998;23.
5. Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys. 52:2002;6-13.
6. D'Amico A.V. Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer. Urology. 58:(Suppl. 2A):2001;78-82.
7. D'Amico A.V., Schultz D., Lofreddo M. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for men with clinically localized prostate cancer. J Am Med Assoc. 284:2000;1280-1283.
8. Demanes D.J., Rodriguez R.R., Altieri G.A. High dose rate prostate brachytherapy: the California Endocurietherapy (CET) method. Radiother Oncol. 57:2000;289-296.
9. Dinges S., Deger S., Koswig S., et al. High-dose-rate with external beam irradiation for localized prostate cancer - results of a prospective trial. Radiother Oncol. 48:1998;197-202.
10. Galalae R.M., Kovacs G., Schultze J., et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys. 52:2002;81-90.
11. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am. 5:1999;152-158.
12. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization and future directions. Int J Radiat Oncol Biol Phys. 41:1998;501-510.
13. Hoskin P.J. High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer. Radiother Oncol. 57:2000;285-288.
14. Hsu I.C., Pickett B., Shinohara K., et al. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation. Int J Radiat Oncol Biol Phys. 46:2000;851-858.
15. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
16. Kini V.R., Edmundson G.K., Vicini F.A., Jaffray D.A., Gustafson G., Martinez A.A. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants. Int J Radiat Oncol Biol Phys. 43:1999;571-578.
17. Kolotas C., Baltas D., Zamboglou N. CT-based interstitial HDR brachytherapy. Strahlenther Onkol. 175:1999;419-427.
18. Koutrouvelis P., Lailes N., Hendricks F., et al. Three-dimensional computed tomography-guided monotherapeutic pararectal brachytherapy of prostate cancer with seminal vesicle invasion. Radiother Oncol. 60:2001;31-35.
19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
20. Martin T., Hey-Koch S., Strassmann G., et al. 3D interstitial HDR brachytherapy combined with 3D external beam radiotherapy and androgen deprivation for prostate cancer - preliminary results. Strahlenther Onkol. 176:2000;361-367.
21. Martin T., Kolotas C., Dannenberg T., et al. New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation. Radiother Oncol. 52:1999;257-260.
22. Martinez A.A., Gonzales J.A., Chung A.K., et al. A comparison of external beam radiation therapy versus radical prostatectomy in patients with low-risk prostate cancer diagnosed, staged, and treated at a single institution. Cancer. 88:2000;425-432.
23. Martinez A.A., Kestin L.L., Stromberg J.S., et al. Interim report of conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial. Int J Radiat Oncol Biol Phys. 47:2000;343-352.
24. Mate T.P., Gottesman J.E., Hatton J., et al. High dose-rate afterloading iridium-192 prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys. 41:1998;525-533.
25. Middleton R.G., Thompson I.M., Austenfeld M.S. Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J Urol. 154:1995;2144-2148.
26. Nath R., Roberts K., Ng M., Peschel R., Chen Z. Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants. Med Phys. 25:1998;2293-2307.
27. Pellizzon A.C.A., Nadalin W., Salvajoli J.V., et al. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Radiother Oncol. 66:2003;167-172.
28. Perez C.A. Prostate. Perez C.A. Principles and practice of radiation oncology. 3rd ed:1997;1583-1694 Lippincott-Raven, Philadelphia, PA.
29. Pilepich M.V., Winter K., John M.J., et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 50:2001;1243-1252.
30. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomised trial. Int J Radiat Oncol Biol Phys. 53:2002;1097-1105.
31. Rodriguez R., Quackenbush J., Schour L., et al. High dose rate brachytherapy and external beam irradiation for prostate cancer. ABS Proceedings (Abstract). 53-PR:2001;. p. 53.
32. Tsalpatouros A., Baltas D., Kolotas C., et al. CT based software for 3D localization and reconstruction in stepping source brachytherapy. IEEE Trans Information Technol Biomed. 4:1997;229-242.
33. Whittington R., Broderick G.A., Arger P., et al. The effect of androgen deprivation on the early changes in prostate volume following transperineal ultrasound guided interstitial therapy for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 44:1999;1107-1110.
34. Yan D., Ziaja E., Jaffray D., et al. The use of adaptive radiation therapy to reduce setup error: a prospective clinical study. Int J Radiat Oncol Biol Pys. 41:1998;715-720.
35. Zamboglou N., Kolotas C., Baltas D. Speiser B.L., Mould R.F. Clinical evaluation of CT based software in treatment planning for interstitial HDR brachytherapy. 1st ed Brachytherapy for the 21st century. 1998;312-326 Nucletron, Veenendaal.
36. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Locally advanced prostate cancer: dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.